Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. Pivotal Therapeutics' lead product VASCAZEN® is a prescription only Medical Food specifically formulated for the dietary management of Omega-3 Deficiency (OM3D) in Cardiovascular Patients. VASCAZEN® is a >90% pure Omega-3 with a proprietary 6:1 EPA:DHA fatty acid formulation, protected by a series of both US and foreign patents. VASCAZEN® is the first and only prescription Omega-3 Medical Food product specifically formulated to address an OM3D in cardiovascular patients. VASCAZEN® is available by prescription nationwide with extensive private insurance coverage.